Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

Mer­ck is mak­ing its fourth ac­qui­si­tion of the year, this time buy­ing a sin­gle as­set from a Shang­hai-based can­cer drug de­vel­op­er.

The New Jer­sey phar­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

How Young Is Too Young For Botox?

Welcome to Culture Clinic, MedPage Today‘s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Cosmetic treatments such

Read More »